Therapeutic points of intervention and clinical implications: Role of desloratadine

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 57, Issue 75, 2002, Pages 13-18

  Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Allergic rhinitis; Asthma; Desloratadine

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; CETIRIZINE; DESLORATADINE; EBASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; LORATADINE; MIZOLASTINE; SALBUTAMOL; TERFENADINE;

ALLERGIC RHINITIS; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; ATOPY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; NONHUMAN; PERENNIAL RHINITIS; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ASTHMA; CLINICAL TRIALS; DRUG ADMINISTRATION SCHEDULE; HISTAMINE H1 ANTAGONISTS; HUMANS; LORATADINE; RHINITIS, ALLERGIC, PERENNIAL; URTICARIA;

EID: 84879643320     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. PAWANKAR R, YAMAGISHI S, YAGI T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol 2000;14:309-317.
2. BOUSQUET J, VAN CAUWENBERGE P, KHALTAEV N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108:S147-S334.
3. VAN CAUWENBERGE P, BACHERT C, PASSALACQUA G et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-134.
4. CIPRANDI G, VIZZACCARO A, CIRILLO I, CRIMI P, CANONICA G. Increase of asthma and allergic rhinitis prevalence in young Italian men. Int Arch Allergy Immunol 1996;111:279-283.
5. STRACHAN D, SIBBALD B, WEILAND S et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8(Suppl. 5):161-176.
6. 1-receptors. J Allergy Clin Immunol 2000;104:S385.
7. GEHA RS, MELTZER EO. Desloratadine: a new, nonsedating, oral antihistamine. J Allergy Clin Immunol 2001;107:751-762.
8. GENOVESE A, PATELLA V, DE CRESCENZO G, DE PAULIS A, SPADARO G, MARONE G. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon R1+ cells. Clin Exp Allergy 1997;27:559-567.
9. LIPPERT U. Binding and antiallergic characteristics of desloratadine. Abstract 325. Allergy 2001;56(Suppl. 68): 112.
10. LEBEL B, BOUSQUET J, CZARLEWSKI W et al. Loratadine (L) reduces RANTES release by an epithelial cell line. J Allergy Clin Immunol 1997;99:S44.
11. 1-antagonist descarboethoxy-loratadine and dexamethasone by human mast and basophilic cell lines. Exp Dermatol 1995;4:272-276.
12. SCHROEDER JT, SCHLEIMER RP, LICHTENSTEIN LM, KREUTNER W. Inhibition of cytokine generation and mediator release by human basophils treated with desloratadine. Clin Exp Allergy 2001;31:1369-1377.
13. VIGNOLA AM, CRAMPETTE L, MONDAIN M et al. Inhibitory activity of loratadine and descarboethoxyloratadine on expression of ICAM-1 and HLA-DR by nasal epithelial cells. Allergy 1995;50:200-203.
14. BACHERT C, DE SCHRYVER L, HOLTAPPELS G. Effects of desloratadine (DL) on human monocyte activity in-vitro. Allergy 2002;57(Suppl. 73):145.
15. MOLET S, GOSSET P. LASSALLE P, CZARLEWSKI W, TONNEL AB. Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells. Clin Exp Allergy 1997;27:1167-1174.
16. STRAFF B, SACHS B, ERDMANN S, MERK HF. Wasp venom-induced IL-5, IL-10, and IFN-γ secretion from human PBMC from patients with wasp venom allergy is diversely inhibited by loratadine, desloratadine and cimetidine. Allergy 2002;57(Suppl. 73):155.
17. WITTMANN M, STUNKEL T, KAPP A, WERFEL T. Immunoregulatory influence of descarboxyloratadine (DCL) on human lymphocytes. Allergy 2002;57(Suppl. 73):147.
18. BACHERT C. Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. Allergy 2001;56(Suppl. 56):14-20.
19. BILLER H, KUNZE S, LUTTMAN W, VIRCHOW JC. Effects of desloratadine (DL) on Th2-cytokine secretion of peripheral blood leukocytes from patients with allergic rhinitis, patients with allergic asthma, and healthy controls. Allergy 2002;57(Suppl. 73):146.
20. AGRAWAL DK, BERRO A, TOWNLEY RG. Desloratadine attenuation of eosinophil chemotaxis, adhesion, and superoxide generation. Allergy 2000;55(Suppl. 63):276.
21. HUGER M, TRAIDL-HOFFMANN C, KASCHE A, RING J, BEHRENDT H. Influence of desloratadine on the chemotactic activity of human polymorphonuclear leukocytes. Allergy 2002;57(Suppl. 73):38.
22. MARSHALL G, HENNINGER E, MANIATIS E, RITTER S, SALICRU A, MESSICK C. Immunomodulatory effects of desloratadine: changes in type-1/type-2 cytokine expression in PBMC cultures. J Allergy Clin Immunol 2002;109(Suppl.):S206-S207.
23. CYR MM, BAATJES AJ, HAYES LM, CRAWFORD L, DENBURG JA. The effect of desloratadine on eosinophil/basophil progenitors and other inflammatory markers in seasonal allergic rhinitis: a placebo-controlled randomized study. Abstract 329. J Allergy Clin Immunol 2002;109:S117.
24. DUBUSKE L. Once-daily desloratadine reduces the symptoms of perennial allergic rhinitis for at least 4 weeks. J Allergy Clin Immunol 2001;107:S159.
25. 1-receptor antagonist, in patients with seasonal allergic rhinitis assessment during the spring and fall allergy season. Clin Drug Invest 2001;21:25-32.
26. RING J, HEIN R, GAUGER A, BRONSKY E, MILLER B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:72-76.
27. RATNER PH, GROUP DS. Desloratadine improved asthma symptoms and reduce bronchodilator use in 2 studies of patients with asthma and SAR. Allergy Asthma Immunol 2000;86:109.
28. WILKEN JA, KANE RL. The differential impacts of diphenhydramine and desloratadine on vigilance and cognitive functioning in subjects with ragweed induced allergic rhinitis. Allergy 2002;57(Suppl. 73):236.
29. PLENKER A, BACHERT C. Treatment of seasonal allergic rhinitis with desloratadine: results of a large German observational study. Allergy 2002;57(Suppl. 73):47-48.
30. Data on file. Schering-Plough, 2002.
31. BACHERT C, VIRCHOW CJ, PLENKER A. Desloratadine in the treatment of seasonal allergic rhinitis: results of a large observational study. Clin Drug Invest 2002;22(Suppl. 2):43-52.